TMS (transcranial magnetic stimulation) is FDA-cleared for major depressive disorder and OCD — but for ADHD, the picture is different. The application of TMS to attention-deficit/hyperactivity disorder is emerging, off-label, and still accumulating its evidence base. At the Houston Center for Advanced Psychiatric Treatment, we offer Deep TMS for ADHD using the BrainsWay system, and we are direct with every patient who inquires about it: this is not a first-line treatment, the evidence is preliminary, and candidacy requires a careful evaluation. What the research suggests so far, and what our clinical experience with this population reflects, is worth understanding clearly before deciding whether to explore it.
What ADHD Is and Why Neural Stimulation Is Being Studied
ADHD (attention-deficit/hyperactivity disorder) is a neurodevelopmental disorder — a condition rooted in brain development and function — characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with daily functioning. It is not a condition of insufficient effort or poor discipline. It reflects differences in how specific brain circuits — particularly the prefrontal cortex and its connections to attention and executive function networks — develop and operate.
The prefrontal cortex (PFC) is the part of the brain most associated with executive functions: sustained attention, working memory, impulse control, and the ability to regulate behavior in response to goals. In ADHD, the prefrontal networks that regulate these functions are underactive relative to neurotypical function — a pattern that standard stimulant medications address pharmacologically by increasing dopamine and norepinephrine availability in those circuits.
The rationale for investigating TMS in ADHD is grounded in this same neurobiology. TMS works by delivering magnetic pulses to targeted brain regions, stimulating neural circuits and promoting neuroplasticity — the formation and strengthening of new neural connections. If ADHD reflects underactivity in prefrontal circuits, then targeted stimulation of those circuits through TMS is a mechanistically coherent hypothesis worth studying. Whether it translates to clinically meaningful improvement, and for which patients, is the question the emerging literature is working to answer.
The Evidence Base: What We Know and What We Don’t
Being transparent about the evidence is the standard we hold ourselves to at our practice, and the evidence for TMS in ADHD is preliminary. This is not a reason to dismiss the approach — preliminary evidence for interventions that address unmet clinical need is exactly how the treatment landscape for depression and OCD looked before the FDA clearances that now cover those indications. It is a reason to be precise about what the research currently shows and what remains under investigation.
Early clinical studies of TMS applied to prefrontal regions in adults with ADHD have reported reductions in inattention symptoms and improvements in executive function measures. BrainsWay, whose Deep TMS system we use at our practice, has conducted research specifically on the H-coil design’s ability to reach the deeper prefrontal structures relevant to attention regulation — structures that surface-level coils may not engage as effectively. The H-coil is used in our Deep TMS therapy for ADD and ADHD protocol at our practice, which targets these deeper circuits directly.
What the research does not yet provide is the kind of large-scale, randomized, controlled trial data that supports the FDA-cleared indications for depression and OCD. Studies to date have generally been smaller, shorter in duration, and more varied in methodology than the trials that underlie cleared indications. This means we cannot cite the same confidence intervals or response rates for ADHD that we can for depression. Results vary by individual, and the clinical picture for any specific patient with ADHD depends on factors that cannot be predicted from early population-level data alone.
Who This Protocol Is Designed For
Our ADD/ADHD dTMS protocol is designed for adults who are interested in a non-pharmacological approach to ADHD symptom management, or who have not achieved adequate relief from stimulant medications or other pharmacological treatments. It is not a replacement for medications that are working well, and we do not recommend stopping effective pharmacological treatment to pursue TMS instead. For patients who prefer to avoid stimulants for medical or personal reasons, or whose stimulant medications have produced inadequate benefit or unwanted side effects, TMS represents an alternative mechanism worth evaluating.
The protocol at our practice runs 15 treatments over three weeks, with sessions delivered on a daily basis, Monday through Friday. Each session uses the BrainsWay Deep TMS system with the H-coil targeting prefrontal circuits associated with attention regulation. Sessions run approximately 20 minutes, with no anesthesia, no sedation, and no restriction on driving or daily activity afterward.
This protocol is not covered by insurance and is available on a self-pay basis. We discuss cost during the consultation and provide straightforward information about what the commitment involves before any treatment is scheduled.
How This Differs from TMS for Depression
Patients who have heard of TMS primarily in the context of depression sometimes ask whether the ADHD protocol is simply the same treatment applied to a different condition. The answer is no — and the distinction matters.
For depression, TMS therapy in Houston targets the left dorsolateral prefrontal cortex (LDLPFC) using a specific stimulation protocol validated across decades of research and FDA review. For ADHD, the target regions and stimulation parameters reflect the distinct neural circuitry underlying attention dysregulation, and the protocol is calibrated accordingly. The same BrainsWay system is used, but the coil positioning, stimulation pattern, and treatment goal are different. Using the depression protocol for an ADHD patient, or assuming that any prior TMS experience maps directly to this application, would be clinically inaccurate.
Deep TMS’s capacity to reach deeper brain structures than conventional surface coils is particularly relevant here. The prefrontal circuits involved in attention regulation include structures that sit beyond the reach of standard figure-8 coils, which is one reason the H-coil system is the appropriate technology for this application. This is not a generic TMS offering — it is a targeted protocol using a specific device with the anatomical reach the application requires.
Two Barriers Worth Addressing
Skepticism about a treatment that isn’t FDA-approved for ADHD. This is a legitimate concern, and we do not ask patients to set it aside. Off-label treatments occupy a well-established role in medicine — many interventions are used and studied outside their original FDA indications, and clinical practice routinely moves ahead of regulatory approval timelines when the underlying evidence and biological rationale are sound. We are transparent about where TMS for ADHD currently sits: emerging evidence, off-label status, and a mechanistically coherent hypothesis. We do not present it as equivalent to our FDA-cleared protocols for depression. We present it as what it is — a thoughtfully applied emerging treatment for patients who have not found adequate relief through standard approaches and who want to explore their options with a provider who will be honest about the evidence.
Cost and the uncertainty it creates. An off-label protocol that is not covered by insurance, applied to a condition with preliminary evidence, can feel like a significant financial commitment under conditions of uncertainty. We understand that. Our goal in the consultation is to give patients enough clinical information to make a genuinely informed decision: what the research currently supports, what our clinical protocol involves, what results vary by individual means in practice, and what the realistic expectations are. We do not oversell this protocol, and we do not discourage appropriate candidates from considering it. If it is not the right fit for a specific patient, we say so. Patients who want to review what others have experienced with our care are welcome to read our patient testimonials.
Frequently Asked Questions
Is TMS FDA-approved for ADHD? No. TMS is FDA-cleared for major depressive disorder and OCD. For ADHD, TMS is currently an off-label application — meaning it is used outside its approved indications based on emerging clinical evidence and biological rationale. We are transparent about this with every patient who inquires. Off-label use is common in medicine and does not mean a treatment is unvalidated, but it does mean the evidence base is less established than for cleared indications. Discuss this openly with our team during consultation.
What does a TMS treatment session for ADHD feel like? Sessions use the same BrainsWay Deep TMS helmet system used for our depression protocols. Patients are awake and seated comfortably throughout the approximately 20-minute session. Most describe a tapping sensation on the scalp, which typically decreases in intensity after the first few sessions. There is no sedation, no recovery period, and no restriction on driving or daily activity after the session. For a detailed look at what to expect, see our page on what to expect for TMS treatment.
Can I do TMS for ADHD while staying on my current ADHD medications? In most cases, yes. TMS does not require stopping existing medications, and our evaluation will review your full medication regimen before treatment begins. Whether any adjustments are appropriate depends on your specific history and current treatment. We do not make blanket recommendations in either direction — that assessment happens during consultation.
How many sessions does the ADHD protocol involve? Our ADD/ADHD dTMS protocol consists of 15 treatments over three weeks, delivered Monday through Friday. Each session runs approximately 20 minutes using the BrainsWay H-coil system targeting prefrontal circuits associated with attention regulation.
What if TMS for ADHD doesn’t produce adequate improvement? TMS for ADHD is one of several options we can discuss for patients whose symptoms have not been adequately addressed by standard approaches. If the protocol does not produce sufficient benefit, we continue the clinical conversation about what else may be relevant to your situation. A non-response to one treatment approach is information, not a conclusion, and we approach your care accordingly. Learn more about the full range of available options on our services page.
Key Takeaways
- TMS for ADHD is an off-label, emerging application — not FDA-approved for this indication. Early research is promising but less established than the evidence base supporting FDA-cleared uses of TMS for depression and OCD.
- The biological rationale is sound: ADHD reflects underactivity in prefrontal circuits that regulate attention and executive function, and TMS applied to those circuits addresses the same mechanism that stimulant medications engage pharmacologically.
- Our ADD/ADHD dTMS protocol uses the BrainsWay H-coil system, which reaches deeper prefrontal structures than conventional surface coils — the appropriate technology for this specific application.
- The protocol consists of 15 sessions over three weeks, is available on a self-pay basis, and is not covered by insurance. We discuss cost directly during consultation.
- Results vary by individual; we are transparent about the evidence base and do not present this protocol as equivalent to our FDA-cleared depression and OCD treatments.
TMS for ADHD represents a genuinely interesting clinical development for patients who have not found adequate relief through standard pharmacological approaches — and we offer it at our practice because we believe in giving patients access to evidence-informed options, not just approved ones. What we will not do is overstate what the current evidence shows. To understand the broader landscape of what treatment-resistant and hard-to-treat conditions look like in clinical practice, our post on 4 Things We Now Know About Treatment-Resistant Depression provides useful context. If you are in Houston and want an honest assessment of whether our ADHD dTMS protocol is worth pursuing for your specific situation, a consultation is the right starting point. Schedule a consultation with our team — call us at 832-436-4055 or reach out online. We will give you a clear and direct answer.
References
Deep TMS. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC10523198/
BrainsWay Deep TMS Device. BrainsWay. https://www.brainsway.com/
TMS Therapy and Neuroplasticity. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC9313265/
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. TMS for ADHD is an off-label application and should only be pursued under the supervision of a licensed psychiatric provider who is familiar with your full medical and psychiatric history. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.